Press "Enter" to skip to content

Contrast Injector Market To Report Impressive Growth, Revenue To Surge To US$889.3 Million By 2022

With the presence of a large pool of participants, the global contrast injector market for is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). GE Healthcare, AngioDynamics, Nemoto Kyorindo Co. Ltd., and Sino Medical- Device Technology Co. Limited are some of the key vendors of contrast injector across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the contrast injector market study.

Citing an instance, in August 2018, a new research paper published in the Annals of Allergies, Asthma, and Immunology found that large number of subjects did not regularly carry their prescribed epinephrine auto-injectors, in spite of having experienced severe reactions in the past. The study revealed that patients require more education on epinephrine auto-injectors. 

Download Free PDF Research Report Brochure @

As estimated in this report, the global contrast injector market stood at US$660.0 million in 2016. Witnessing a tremendous rise during the period from 2017 to 2022, the revenue in this contrast injector market is expected to reach US$889.3 million by the end of the forecast period. The main products available in this contrast injector market are injector systems, consumables, and accessories. Among the three, the demand for injector system is relatively higher and the trend is anticipated to remain so over the next few years, notes the research report.

Rising Cases of Traumatic Ailments To Boost Market Growth

“Escalating demand for non-invasive diagnosis and early disease diagnosis are the major growth drivers of contrast injector market in the near future,” says the author of this contrast injector market study. Apart from this, rising cases of various kinds of cancers, heart ailments, and trauma witnessed in the rising elderly population will further spur the contrast injector market trends over the span of next few years.

Get Free Sample Report of Contrast Injector Market @

Increased costs and concerns raised by FDA over approval of the product in certain countries, however, are some of the factors projected to limit the growth of the global contrast injector market in the near future. In addition, adverse effects and allergic reactions related to contrast agents may hamper the growth of the business. Nevertheless, untapped market potential and technological developments are expected to generate new growth opportunities for contrast injector market during the forecast timeline, thereby normalizing the impact of hindrances on the contrast injector market, reports the contrast injector market study.

Presence of Advanced Healthcare Infrastructure To Aid Regional Dominance

Regionally, North America has been leading the worldwide contrast injector market and is anticipated to continue on the dominant position in the years to come, states the contrast injector market study. The presence of a well-established medical and healthcare infrastructure and skilled healthcare professionals is the main factor behind the dominance of the North America contrast injector market. The high number of market players being headquartered in North America is another significant factor that is supporting this regional contrast injector market.

For more information Visit@

The global contrast injector market is segmented as follows:

By Product

  • Injector Systems
    • CT Injector Systems
    • MRI Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Heads
      • Single Head Injectors
      • Dual Head Injectors
      • Syringe less Injectors